Current Volume 10
Background: Although rural communities are disproportionately affected by chronic disease, they are also clearly suffering from the chronic shortage of health-care providers. Community pharmacists are increasingly being recruited as key stakeholders to lead population health initiatives as they serve as the most accessible health care access points in many rural communities, but the scope of these initiatives, their impact on chronic disease care and health utilization has not been comprehensively understood and mapped. Objective: To bring together the latest available evidence to explore, define and synthesise contemporary community pharmacist led population health initiatives in rural areas, their mechanisms, and the potential health-economic, health system and humanistic outcomes, including health-care utilization and cost. Methods: A systematic review was performed using a scoping framework developed by Arksey and O'Malley and reporting standards recommended in the PRISMA-ScR guidelines, which included mapping peer-reviewed literature up to and including 2024 into systematic reviews, economic analyses, randomised trials and rural programme evaluations. Twenty sources are charted, with the setting, the type of interventions and the mechanisms and the outcome domain. Results: Pharmacist-led initiatives were grouped (medication therapy management, telehealth and telepharmacy, screening and risk reduction, and collaborative care). In these, interventions were shown to impact positively on adherence to medication, disease control, and quality of life and a slowly expanding and body of evidence were used to show relationships with reduced health-service usage and positive health-economic effects. Reimbursement, staffing and infrastructure issues specific to rural practice influenced implementation. Conclusion: Community pharmacists can effectively be utilised as part of a viable and viable approach towards underpinning rural chronic disease management and reducing the burdens facing rural health systems. They can only be realized if they receive a flexible and sustainable reimbursement, receive investment in a telepharmacy infrastructure, and get consistent measurement of utilization and cost outcomes.
IRE Journals:
Harry S Patel "The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities" Iconic Research And Engineering Journals Volume 9 Issue 5 2025 Page 2866-2879 https://doi.org/10.64388/IREV9I5-1719515
IEEE:
Harry S Patel
"The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities" Iconic Research And Engineering Journals, vol. 9, no. 5, Nov. 2025, doi: https://doi.org/10.64388/IREV9I5-1719515
APA:
Harry S Patel
(2025). The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities. Iconic Research And Engineering Journals, 9(5). doi: https://doi.org/10.64388/IREV9I5-1719515
MLA:
Harry S Patel
"The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities" Iconic Research And Engineering Journals, vol. 9, no. 5, Nov. 2025. Crossref, https://doi.org/10.64388/IREV9I5-1719515
@article{1719515,
author = {Harry S Patel},
title = {The Impact of Community Pharmacist-Led Population Health Initiatives On Chronic Disease Management and Healthcare Utilization Reduction in Rural Communities},
journal = {Iconic Research And Engineering Journals},
year = {2025},
volume = {9},
number = {5},
pages = {2866-2879},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1719515.pdf},
abstract = {Background: Although rural communities are disproportionately affected by chronic disease, they are also clearly suffering from the chronic shortage of health-care providers. Community pharmacists are increasingly being recruited as key stakeholders to lead population health initiatives as they serve as the most accessible health care access points in many rural communities, but the scope of these initiatives, their impact on chronic disease care and health utilization has not been comprehensively understood and mapped.
Objective: To bring together the latest available evidence to explore, define and synthesise contemporary community pharmacist led population health initiatives in rural areas, their mechanisms, and the potential health-economic, health system and humanistic outcomes, including health-care utilization and cost.
Methods: A systematic review was performed using a scoping framework developed by Arksey and O'Malley and reporting standards recommended in the PRISMA-ScR guidelines, which included mapping peer-reviewed literature up to and including 2024 into systematic reviews, economic analyses, randomised trials and rural programme evaluations. Twenty sources are charted, with the setting, the type of interventions and the mechanisms and the outcome domain.
Results: Pharmacist-led initiatives were grouped (medication therapy management, telehealth and telepharmacy, screening and risk reduction, and collaborative care). In these, interventions were shown to impact positively on adherence to medication, disease control, and quality of life and a slowly expanding and body of evidence were used to show relationships with reduced health-service usage and positive health-economic effects. Reimbursement, staffing and infrastructure issues specific to rural practice influenced implementation.
Conclusion: Community pharmacists can effectively be utilised as part of a viable and viable approach towards underpinning rural chronic disease management and reducing the burdens facing rural health systems. They can only be realized if they receive a flexible and sustainable reimbursement, receive investment in a telepharmacy infrastructure, and get consistent measurement of utilization and cost outcomes.},
month = {November}
}